Dupont Capital Management Corp purchased a new position in Concert Pharmaceuticals Inc (NASDAQ:CNCE) during the second quarter, HoldingsChannel reports. The institutional investor purchased 30,525 sha
Concert (CNCE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its second quarter 2020 financial results on Thursday, August 6, 2020, before the U.S. financial markets open. The Comp
CTP, the leading premium industrial parks developer and long-term manager in Romania and Central and Eastern Europe, continues its expansion in Romania by
The FDA granted Breakthrough Therapy Designation for CTP-543 for the treatment of moderate-to-severe alopecia areata.
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile market
Brokerages predict that Concert Pharmaceuticals Inc (NASDAQ:CNCE) will announce $10,000.00 in sales for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Con
Zacks Investment Research upgraded shares of Concert Pharmaceuticals (NASDAQ:CNCE) from a hold rating to a buy rating in a research note issued to investors on Tuesday, Zacks.com reports. Zacks Invest
Squarepoint Ops LLC reduced its position in Concert Pharmaceuticals Inc (NASDAQ:CNCE) by 29.8% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4

Concert (CNCE) Upgraded to Buy: Here's Why

04:00pm, Tuesday, 30'th Jun 2020
Concert (CNCE) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is (CNCE) Outperforming Other Medical Stocks This Year?
Following up on 7 bonus solar + storage articles — very cool stories that we just didn't get to covering in standalone pieces — here are 5 bonus electric vehicle battery stories.

Insider Sells Concert Pharmaceuticals' Shares

02:39pm, Wednesday, 24'th Jun 2020
Shares of Concert Pharmaceuticals Inc (NASDAQ:CNCE) fell by 1.8% from the previous closing price. Stuart Nancy filed a Form 4 with the SEC on Wednesday, June 24. The insider sold 10,295 shares at an a
Joe Ritchie-Bennett, from Philadelphia in the US, had been working for a Dutch pharmaceutical company in Reading, Berkshire, and lost his husband Ian, 32, to colon cancer in 2014.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE